Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.

A series of bisaryldiketene derivatives were designed and synthesized as a new class of specific G-quadruplex ligands. The ligand-quadruplex interactions were further evaluated by FRET, ITC, and PCR stop assay. In contrast to most of the G-quadruplex ligands reported so far, which comprise an extended aromatic ring, these compounds are neither polycyclic nor macrocyclic, but have a non-aromatic and relative flexible linker between two quinoline moieties enabling the conformation of compounds to be flexible. Our results showed that these bisaryldiketene derivatives could selectively recognize G-quadruplex DNA rather than binding to duplex DNA. Moreover, they showed promising discrimination between different G-quadruplex DNA. The primary binding affinity of ligand M2 for c-myc G-quadruplex DNA was over 200 times larger than that for telomere G-quadruplex DNA.

[1]  P. Pečinka,et al.  DNA tetraplex formation in the control region of c-myc. , 1998, Nucleic acids research.

[2]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[3]  Ding Li,et al.  Turning off transcription of the bcl-2 gene by stabilizing the bcl-2 promoter quadruplex with quindoline derivatives. , 2010, Journal of medicinal chemistry.

[4]  B. Pagano,et al.  Energetics of quadruplex-drug recognition in anticancer therapy. , 2007, Current cancer drug targets.

[5]  Stephen Neidle,et al.  Human telomeric G‐quadruplex: The current status of telomeric G‐quadruplexes as therapeutic targets in human cancer , 2010, The FEBS journal.

[6]  M. Teulade‐Fichou,et al.  A hitchhiker's guide to G-quadruplex ligands. , 2008, Organic & biomolecular chemistry.

[7]  Yiqiang Zhao,et al.  Genome-wide colonization of gene regulatory elements by G4 DNA motifs , 2009, Nucleic acids research.

[8]  Danzhou Yang,et al.  Polymorphism of human telomeric quadruplex structures. , 2008, Biochimie.

[9]  K. Shin‐ya,et al.  Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. , 2001, Journal of the American Chemical Society.

[10]  Yi Zhang,et al.  Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation , 2008, Nucleic acids research.

[11]  L. Hurley,et al.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics , 2009, Nature Reviews Cancer.

[12]  Sarah W. Burge,et al.  Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter. , 2007, Journal of the American Chemical Society.

[13]  B. Pagano,et al.  Applications of Isothermal Titration Calorimetry in Biophysical Studies of G-quadruplexes , 2009, International journal of molecular sciences.

[14]  S. Balasubramanian,et al.  G-quadruplex recognition by bis-indole carboxamides. , 2008, Chemical communications.

[15]  A. Phan,et al.  Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter , 2005, Nature chemical biology.

[16]  Jia-Heng Tan,et al.  Design of selective G-quadruplex ligands as potential anticancer agents. , 2008, Mini reviews in medicinal chemistry.

[17]  Stephen Neidle,et al.  The structures of quadruplex nucleic acids and their drug complexes. , 2009, Current opinion in structural biology.

[18]  Hai-bin Luo,et al.  Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA. , 2009, Journal of medicinal chemistry.

[19]  Stephen Neidle,et al.  Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes. , 2010, Journal of the American Chemical Society.

[20]  Sarah W. Burge,et al.  Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.

[21]  L. Hurley,et al.  Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2 P1 promoter. , 2006, Journal of the American Chemical Society.

[22]  S. Balasubramanian,et al.  Diarylethynyl amides that recognize the parallel conformation of genomic promoter DNA G-quadruplexes. , 2008, Journal of the American Chemical Society.

[23]  A. Phan,et al.  DNA architecture: from G to Z. , 2006, Current opinion in structural biology.

[24]  N. Maizels,et al.  High Affinity Interactions of Nucleolin with G-G-paired rDNA* , 1999, The Journal of Biological Chemistry.

[25]  A. Firulli,et al.  Ribonucleoprotein and protein factors bind to an H-DNA-forming c-myc DNA element: possible regulators of the c-myc gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Chan,et al.  Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. , 2007, Journal of medicinal chemistry.

[27]  Giuseppe Bifulco,et al.  Structural and thermodynamic studies of the interaction of distamycin A with the parallel quadruplex structure [d(TGGGGT)]4. , 2007, Journal of the American Chemical Society.

[28]  S. Balasubramanian,et al.  Controlled-folding of a small molecule modulates DNA G-quadruplex recognition. , 2009, Chemical communications.

[29]  Stephen Neidle,et al.  Quadruplex DNA crystal structures and drug design. , 2008, Biochimie.

[30]  J. Mergny,et al.  Highly efficient G-quadruplex recognition by bisquinolinium compounds. , 2007, Journal of the American Chemical Society.

[31]  J. Snyder,et al.  Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. , 2004, Bioorganic & medicinal chemistry.

[32]  L. Hurley,et al.  The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression. , 2009, Journal of medicinal chemistry.

[33]  W. Gilbert,et al.  Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis , 1988, Nature.

[34]  Laurence H. Hurley,et al.  Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents , 2005, Nucleic acids research.

[35]  D. Bearss,et al.  Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. C. Hardin,et al.  Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine·guanine base pairs , 1987, Cell.

[37]  S. Neidle,et al.  Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. , 2006, Journal of the American Chemical Society.

[38]  Patrick Mailliet,et al.  Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase. , 2004, Biochemical and biophysical research communications.

[39]  Jean-Louis Mergny,et al.  Targeting telomeres and telomerase. , 2008, Biochimie.

[40]  S. Balasubramanian,et al.  Macrocyclic and helical oligoamides as a new class of G-quadruplex ligands. , 2007, Journal of the American Chemical Society.

[41]  J. Mergny,et al.  Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands , 2005, Oncogene.

[42]  B. Pagano,et al.  Targeting DNA quadruplexes with distamycin A and its derivatives: an ITC and NMR study. , 2008, Biochimie.

[43]  Laurence H. Hurley,et al.  DNA and its associated processes as targets for cancer therapy , 2002, Nature Reviews Cancer.

[44]  Gary Parkinson,et al.  Telomere maintenance as a target for anticancer drug discovery , 2002, Nature Reviews Drug Discovery.

[45]  Kwok‐yin Wong,et al.  G‐Quadruplexes: Targets in Anticancer Drug Design , 2008, ChemMedChem.

[46]  Stephen Neidle,et al.  Putative DNA quadruplex formation within the human c-kit oncogene. , 2005, Journal of the American Chemical Society.

[47]  L. Hurley,et al.  The c-MYC NHE III(1): function and regulation. , 2010, Annual review of pharmacology and toxicology.

[48]  S. Berberich,et al.  PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. , 1995, Oncogene.

[49]  W. Hahn,et al.  Telomerase Maintains Telomere Structure in Normal Human Cells , 2003, Cell.

[50]  Stephen Neidle,et al.  Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. , 2006, Journal of medicinal chemistry.

[51]  M. Doyle,et al.  Characterization of binding interactions by isothermal titration calorimetry. , 1997, Current opinion in biotechnology.

[52]  J. Mergny,et al.  Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Jeffery T. Davis.  G-quartets 40 years later: from 5'-GMP to molecular biology and supramolecular chemistry. , 2004, Angewandte Chemie.

[54]  Shankar Balasubramanian,et al.  Prevalence of quadruplexes in the human genome , 2005, Nucleic acids research.

[55]  K. Shin‐ya,et al.  Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. , 2003, Cancer research.

[56]  R. Weinberg,et al.  Telomeres: cancer to human aging. , 2006, Annual review of cell and developmental biology.